Source: Annual Congress 2012 - Diffuse parenchymal lung disease I



Rating:

Share or cite this content

Citations should be made in the following way:
E. Puscinska, M. Bednarek, A. Goljan-Geremek, A. Kowalczyk, J. Chorostowska-Wynimko, P. Jagus, A. Rozy, J. Grudny, D. Chmielewski, D. Gorecka (Warsaw, Poland). The relationship between leptin and proinflammatory cytokines with bone mineral density in patients with sarcoidosis (pts). Eur Respir J 2012; 40: Suppl. 56, 3617

Member's Comments

No comment yet.

Related content which might interest you: Serum leptin level may be a predictor of bone mineral loss in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 688s Year: 2007 Influence of proinflammatory cytokines on osteopenia development in sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 540s Year: 2006 Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006 Content of IL-6, IL-10, TNF-α and leptin in blood of COPD patients depending on stage of disease Source: Eur Respir J 2007; 30: Suppl. 51, 769s Year: 2007 Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 Bone mineral density changes in male patients with chronic obstructive pulmonary disease: clinical and biochemical variables in correlation with glucocorticoids use Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009 Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 Serum levels of undercarboxylated osteocalcin as a biomarker to predict bone mineral density in patients with chronic respiratory diseases Source: Annual Congress 2010 - Rehabilitation: more than just exercise Year: 2010 Bone mineral density (BMD) measuring in patients suffering from pulmonary disease under glucocorticoid treatment - fashioned trend or necessity? Source: Eur Respir J 2005; 26: Suppl. 49, 526s Year: 2005 Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Can leptin and IL-6 influence the nutritional status in COPD patients? Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome Source: International Congress 2015 – COPD: notable points Year: 2015 Serum levels of IL-10 and IL-12 i patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Inflammation and airways Year: 2009 Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease? Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Effect of the COLIA1Sp1 polymorphism on bone density in sarcoidosis patients Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Content of IL-6, IL-10, TNF-α and leptin in blood of COPD patients depending on body mass index Source: Eur Respir J 2007; 30: Suppl. 51, 770s Year: 2007 An evaluation of circulating cytokines milieu in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 311s Year: 2002 TNF-a and IL-10 control macrophage expression of CXCL13, a prognostic biomarker of idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 TNF-alpha, IL-8, IL-6 levels in serum of sarcoidosis patients with different clinical course Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013